Showing results (1301-1310 of 1,419) with videos related to

Sort By:
Pageof 142
Hepatology (Baltimore, Md.)|September 20, 2023
Computational drug prediction in hepatoblastoma by integrating pan-cancer transcriptomics with pharmacological responseMario Failli, Salih Demir, Álvaro Del Río-Álvarez, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1983
Coordinate production by a T cell hybridoma of gamma interferon and three other lymphokine activities: multiple activities of a single lymphokine?A Zlotnik, W K Roberts, A Vasil, et al.
Inquiry : a Journal of Medical Care Organization, Provision and Financing|September 5, 2024
Organizational Characteristics of Hospitals Meeting STRIDE Program Adoption Benchmarks to Support Mobility for Hospitalized PersonsLeah L Zullig, Connor Drake, Amy Webster, et al.
SLAS Discovery : Advancing Life Sciences R & D|October 30, 2016
Unified Software Solution for Efficient SPR Data Analysis in Drug ResearchGöran Dahl, Stephan Steigele, Per Hillertz, et al.
Pediatric Research|September 17, 2015
Surfactant proteins in pediatric interstitial lung diseaseMatthias Griese, Elke Lorenz, Meike Hengst, et al.
Annals of Internal Medicine|June 5, 2023
Effects of Implementation of a Supervised Walking Program in Veterans Affairs Hospitals : A Stepped-Wedge, Cluster Randomized TrialSusan N Hastings, Karen M Stechuchak, Ashley Choate, et al.
Environmental Toxicology and Chemistry|July 18, 2015
A risk-based approach to managing active pharmaceutical ingredients in manufacturing effluentDaniel J Caldwell, Birgit Mertens, Kelly Kappler, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation|July 5, 2024
Enhancing team communication to improve implementation of a supervised walking program for hospitalized veterans: Evidence from a multi-site trial in the Veterans Health AdministrationConnor Drake, Virginia Wang, Karen M Stechuchak, et al.
Diabetes|December 7, 2016
Islet-Derived CD4 T Cells Targeting Proinsulin in Human Autoimmune DiabetesAaron W Michels, Laurie G Landry, Kristen A McDaniel, et al.
Urologic Oncology|February 21, 2026
Progression-free survival with darolutamide and docetaxel vs. androgen receptor pathway inhibitors vs. docetaxel in metastatic hormone-sensitive prostate cancer: A real-world multicenter retrospective studyEmily Rinderknecht, Gloria Bielstein, Richard Cathomas, et al.
Pageof 142